Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I ...

Terence Flynn, Morgan Stanley, inquired about Zepbound payer dynamics and access. Patrik Jonsson explained that Medicare coverage related to obstructive sleep apnea (OSA) is anticipated in the second ...

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...

INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO ...

Eli Lilly & Co.’s full-year earnings forecast came in line with analysts’ estimates as the company works to fix inventory ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

(Bloomberg) -- Eli Lilly & Co.’s fourth-quarter revenue ... precision than market concerns,” Chief Financial Officer Lucas Montarce said Tuesday in an interview with Bloomberg at the JPMorgan ...

(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after it forecast ... As supply normalizes, Lilly's Chief Financial Officer Lucas Montarce said wholesalers did not seek to build up their stocks of ...

(Bloomberg) -- Eli Lilly & Co.’s fourth-quarter revenue fell short of ... “I’d call it more forecasting precision than market concerns,” Chief Financial Officer Lucas Montarce said Tuesday in an ...